BioRestorative Therapies, Inc. (BRTX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q3 '11: 0 Q4 '11: 0 Q1 '12: 0 Q2 '12: 10K Q3 '12: 5.2K Q4 '12: 364 Q1 '13: 1.1K Q2 '13: 425 Q3 '13: 125 Q4 '13: 0 Q1 '14: 375 Q2 '14: 175.9K Q3 '14: 159.9K Q4 '14: 79.8K Q1 '15: 184.9K Q2 '15: 148.8K Q3 '15: 96.1K Q4 '15: 199.1K Q1 '16: 9.1K Q2 '16: 16.2K Q3 '16: 5K Q4 '16: 6.1K Q1 '17: 7K Q2 '17: 20K Q3 '17: 16K Q4 '17: 38K Q1 '18: 19K Q2 '18: 37K Q3 '18: 26K Q4 '18: 29K Q1 '19: 29K Q2 '19: 31K Q3 '19: 38K Q4 '19: 32K Q1 '20: 26K Q2 '20: 19K Q3 '20: 15K Q4 '20: 17K Q1 '21: 18K Q2 '21: 15K Q3 '21: 8K Q4 '21: 5K Q1 '22: 16K Q2 '22: 71.1K Q3 '22: 29K Q4 '22: 3.7K Q1 '23: 31.3K Q2 '23: 64.5K Q3 '23: 30.7K Q4 '23: 19.3K Q1 '24: 35K Q2 '24: 89.1K Q3 '24: 233.6K Q4 '24: 43.3K Q1 '25: 25K Q2 '25: 303.3K Q3 '25: 11.8K Q4 '25: 19.6K Q1 '26: 23.2K Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Gross Profit Quarterly

0 150K 300K 450K Q3 '11: 0 Q4 '11: 0 Q1 '12: 0 Q2 '12: 10K Q3 '12: 4K Q4 '12: 327 Q1 '13: 968 Q2 '13: 389 Q3 '13: 115 Q4 '13: 0 Q1 '14: 315 Q2 '14: 133.6K Q3 '14: 93.8K Q1 '15: 108.5K Q2 '15: 74.1K Q3 '15: 45.2K Q4 '15: 139.6K Q1 '16: 9.1K Q2 '16: 16.1K Q3 '16: 5K Q4 '16: 6.1K Q1 '17: 7K Q2 '17: 20K Q3 '17: 16K Q4 '17: 38K Q1 '23: 31.3K Q2 '23: 64.5K Q3 '23: 30.7K Q4 '23: 19.3K Q1 '24: 35K Q2 '24: 82.6K Q3 '24: 215.4K Q4 '24: 40K Q1 '25: 22.1K Q2 '25: 294.6K Q3 '25: 1.2K Q4 '25: 18K Q1 '26: 15.8K Q1 '12 Q2 '13 Q3 '14 Q1 '16 Q2 '17 Q3 '23 Q4 '24 Q1 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q1 '10: -344K Q2 '10: -178.7K Q3 '10: -370.2K Q4 '10: -1.2M Q1 '11: -1M Q2 '11: -1M Q3 '11: -853K Q4 '11: -643.2K Q1 '12: -1.3M Q2 '12: -1.3M Q3 '12: -1.2M Q4 '12: -1.7M Q1 '13: -1.3M Q2 '13: -1.1M Q3 '13: -1.1M Q4 '13: -1.2M Q1 '14: -1.4M Q2 '14: -1.3M Q3 '14: -896K Q4 '14: -1.3M Q1 '15: -1.6M Q2 '15: -1.3M Q3 '15: -1.5M Q4 '15: -2.8M Q1 '16: -2.1M Q2 '16: -2.1M Q3 '16: -1.7M Q4 '16: -1.9M Q1 '17: -2.5M Q2 '17: -2.6M Q3 '17: -1.7M Q4 '17: -1.6M Q1 '18: -2.2M Q2 '18: -2.1M Q3 '18: -1.2M Q4 '18: -2.2M Q1 '19: -2.3M Q2 '19: -2.1M Q3 '19: -1.8M Q4 '19: -2.2M Q1 '20: -819K Q2 '20: -461.6K Q3 '20: -610.3K Q4 '20: -854.5K Q1 '21: -15.1M Q2 '21: -3.6M Q3 '21: -3.7M Q4 '21: -4M Q1 '22: -5.1M Q2 '22: -4.6M Q3 '22: -4.6M Q4 '22: -4.7M Q1 '23: -5.8M Q2 '23: -3.1M Q3 '23: -3.1M Q4 '23: -3.2M Q1 '24: -4.1M Q2 '24: -2.5M Q3 '24: -2.3M Q4 '24: -2.7M Q1 '25: -4.8M Q2 '25: -3.3M Q3 '25: -3.7M Q4 '25: -3.8M Q1 '26: -3.4M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q4 '23 Q1 '26

Net Income Quarterly

-21M -14M -7M 0 7M 14M 21M Q1 '10: -465.4K Q2 '10: -197.3K Q3 '10: -388.8K Q4 '10: -1.2M Q1 '11: -1.1M Q2 '11: -1.2M Q3 '11: -1M Q4 '11: -742.6K Q1 '12: -1.5M Q2 '12: -1.6M Q3 '12: -1.5M Q4 '12: -1.9M Q1 '13: -1.6M Q2 '13: -1.3M Q3 '13: -1.3M Q4 '13: -1.6M Q1 '14: -1.7M Q2 '14: -1.3M Q3 '14: -1.1M Q4 '14: -1.5M Q1 '15: -1.8M Q2 '15: -1.4M Q3 '15: -1.6M Q4 '15: -3.1M Q1 '16: -2.5M Q2 '16: -2.3M Q3 '16: -1.8M Q4 '16: -2.1M Q1 '17: -2.8M Q2 '17: -2.7M Q3 '17: -2.1M Q4 '17: -1.9M Q1 '18: -2.5M Q2 '18: -3.5M Q3 '18: -2.9M Q4 '18: -3.6M Q1 '19: -3.9M Q2 '19: -4.2M Q3 '19: -5.1M Q4 '19: -1.6M Q1 '20: -7.6M Q2 '20: 2.9M Q3 '20: -836.3K Q4 '20: -5.8M Q1 '21: -15.7M Q2 '21: -4.1M Q3 '21: -4.2M Q4 '21: -20.4M Q1 '22: -4.8M Q2 '22: -4.7M Q3 '22: -4.7M Q4 '22: -2.7M Q1 '23: -7.2M Q2 '23: -5.7M Q3 '23: 4.8M Q4 '23: -2.3M Q1 '24: -2.2M Q2 '24: -4M Q3 '24: -1.1M Q4 '24: -1.6M Q1 '25: -5.3M Q2 '25: -2.7M Q3 '25: -3M Q4 '25: -3.2M Q1 '26: -2.2M Q2 '10 Q3 '12 Q4 '14 Q1 '17 Q2 '19 Q3 '21 Q4 '23 Q1 '26

Cost of Revenue Quarterly

0 7K 14K 21K Q2 '24: 6.5K Q3 '24: 18.2K Q4 '24: 3.3K Q1 '25: 2.9K Q2 '25: 8.7K Q3 '25: 10.6K Q4 '25: 1.6K Q1 '26: 7.4K Q2 '24 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '10: 28.4K Q4 '10: -392.9K Q1 '11: -849.9K Q2 '11: -570.8K Q3 '11: -274.6K Q4 '11: -1.1M Q1 '12: -393.9K Q2 '12: -1.3M Q3 '12: -450.9K Q4 '12: -1.1M Q1 '13: -771.8K Q2 '13: -702.5K Q3 '13: -434.4K Q4 '13: -763.8K Q1 '14: -806.7K Q2 '14: -953.2K Q3 '14: -833.7K Q4 '14: -634.3K Q1 '15: -674.8K Q2 '15: -809.6K Q3 '15: -583.6K Q4 '15: -1.1M Q1 '16: -1.7M Q2 '16: -1M Q3 '16: -1.2M Q4 '16: -1.1M Q1 '17: -1.2M Q2 '17: -766K Q3 '17: -509.2K Q4 '17: -1.4M Q1 '18: -1.2M Q2 '18: -1M Q3 '18: -1.4M Q4 '18: -1.6M Q1 '19: -2M Q2 '19: -1.4M Q3 '19: -1.7M Q4 '19: -1.8M Q1 '20: -448.6K Q2 '20: -420.4K Q3 '20: -523.1K Q4 '20: -572.1K Q1 '21: -813.7K Q2 '21: -741.8K Q3 '21: -629.4K Q4 '21: -1.1M Q1 '22: -1.6M Q2 '22: -1.3M Q3 '22: -1.5M Q4 '22: -1.6M Q1 '23: -2.4M Q2 '23: -1.1M Q3 '23: -1.2M Q4 '23: -1.8M Q1 '24: -2.3M Q2 '24: -1.9M Q3 '24: -1.7M Q4 '24: -2.3M Q1 '25: -2.8M Q2 '25: -2.7M Q3 '25: -2.9M Q4 '25: -2.4M Q1 '26: -3.8M Q1 '12 Q1 '14 Q1 '16 Q1 '18 Q1 '20 Q1 '22 Q1 '24 Q1 '26

Free Cash Flow Quarterly

-3M -2M -1M 0 1M 2M 3M Q3 '10: -41.9K Q1 '11: -856.8K Q2 '11: -581.7K Q3 '11: -274.6K Q4 '11: -1.1M Q1 '12: -393.9K Q2 '12: -1.3M Q3 '12: -450.9K Q4 '12: -1.1M Q1 '13: -771.8K Q2 '13: -702.5K Q3 '13: -434.4K Q4 '13: -774.9K Q1 '14: -806.7K Q2 '14: -953.2K Q3 '14: -835.2K Q4 '14: -801.1K Q1 '15: -766.9K Q2 '15: -869.4K Q3 '15: -792.2K Q4 '15: -1.1M Q1 '16: -1.8M Q2 '16: -1.1M Q3 '16: -1.2M Q4 '16: -1.1M Q3 '18: -1.4M Q4 '18: -1.6M Q3 '19: -1.7M Q4 '19: -1.8M Q1 '22: -1.7M Q2 '22: -1.4M Q3 '22: -1.5M Q4 '22: -1.7M Q1 '23: -2.4M Q2 '23: -1.2M Q3 '23: -1.2M Q4 '23: -1.8M Q3 '24: -1.8M Q4 '24: -2.4M Q1 '25: -2.8M Q2 '25: -2.7M Q3 '25: -2.9M Q4 '25: -2.5M Q3 '10 Q2 '12 Q4 '13 Q2 '15 Q4 '16 Q2 '22 Q4 '23 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 600M 1.2B 1.8B Q2 '19: 17.5M Q2 '20: 1.6B Q1 '21: 729.9K Q2 '21: 795.9K Q3 '21: 838.7K Q1 '22: 3.5M Q2 '22: 3.6M Q3 '22: 3.6M Q1 '23: 3.7M Q2 '23: 3.9M Q3 '23: 12.3M Q1 '24: 6.7M Q2 '24: 8.1M Q3 '24: 8.1M Q1 '25: 8.4M Q2 '25: 8.7M Q3 '25: 9.1M Q1 '26: 17.7M Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q4 '10: 0.00 Q1 '11: 0.00 Q2 '11: 0.00 Q3 '11: 0.00 Q4 '11: 0.00 Q1 '12: -0.13 Q2 '12: -0.25 Q3 '12: -0.36 Q4 '12: -0.48 Q1 '13: -0.45 Q2 '13: -0.41 Q3 '13: -0.38 Q4 '13: -0.36 Q1 '14: -0.34 Q2 '14: -1.43 Q3 '14: -2.16 Q4 '14: -2.93 Q1 '15: -3.85 Q2 '15: -3.32 Q3 '15: -3.08 Q4 '15: -3.30 Q1 '16: -2.99 Q2 '16: -2.91 Q3 '16: -2.77 Q4 '16: -2.11 Q1 '17: -1.98 Q2 '17: -1.93 Q3 '17: -1.87 Q4 '17: -1.76 Q1 '18: -1.59 Q2 '18: -1.61 Q3 '18: -1.63 Q4 '18: -1.63 Q1 '19: -1.52 Q2 '19: -1.23 Q3 '19: -1.07 Q4 '19: -0.66 Q1 '20: -0.39 Q2 '20: -0.15 Q3 '20: -2.02 Q4 '20: -14.74 Q1 '22: -14.31 Q2 '22: -15.59 Q3 '22: -11.88 Q4 '22: -5.61 Q1 '23: -5.21 Q2 '23: -5.40 Q3 '23: -3.73 Q4 '23: -2.47 Q1 '24: -0.87 Q2 '24: 0.10 Q3 '24: -0.42 Q4 '24: -1.16 Q1 '25: -1.47 Q2 '25: -1.27 Q3 '25: -1.47 Q4 '25: -1.59 Q1 '26: -1.07 Q1 '11 Q1 '13 Q1 '15 Q1 '17 Q1 '19 Q1 '22 Q1 '24 Q1 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.